As reduced BRRIAR expression is associated with breast cancer risk variants, we hypothesized that lower BRRIAR levels impair RIG-I activation and contribute to immune suppression, although this effect would likely be limited to a small subset of cells. This evidence concerns the gene RIGI and breast cancer.